GPT and metabolic dysfunction-associated steatotic liver disease: Data extraction captured study design characteristics, participant demographics, intervention details (dose, duration), histological outcomes (NAFLD (nonalcoholic fatty liver disease) Activity Score (NAS) score components, fibrosis stage), biochemical parameters (alanine aminotransferase (ALT)/aspartate aminotransferase (AST)), and adverse events, utilizing a standardized piloted form to ensure consistency.